ICMR Releases Ethical Guidelines for Integrative Medicine Research
The Indian Council of Medical Research (ICMR) has published an addendum to its National Ethical Guidelines for Biomedical and Health Research Involving Human Participants (2017), establishing a structured ethical framework for Research in Integrative Medicine (RIM). The addendum provides clear ethical guidelines for research that combines traditional Ayush systems with modern medical practices, ensuring ethical rigor and regulatory compliance.
CDSCO Launches Online Registration for Clinical Research Organizations (CROs) via SUGAM Portal
The Central Drugs Standard Control Organization (CDSCO) has announced the launch of online registration for Clinical Research Organizations (CROs) through the SUGAM portal. This initiative follows the Ministry of Health and Family Welfare’s notification making CRO registration mandatory from April 1, 2025.
Reforms in Healthcare and Education For A Resilient Future
The Indian Government has announced a series of comprehensive initiatives to boost healthcare and education sectors in the country. These reforms aim to enhance healthcare accessibility, improve medical education, foster research, and promote technological advancement. A press release on these reforms was issued on September 28, 2024.
CDSCO Requires Registration Of Clinical Research Organizations
The Central Drugs Standard Control Organization (CDSCO) has announced amendments to the New Drugs and Clinical Trials Rules, 2019. These amendments aim to strengthen the regulatory framework for clinical research organizations (CROs) in India. CROs are now required to register with the Central Licensing Authority before conducting clinical trials.
CDSCO Seeks Public Input on Revised Good Clinical Practices Guidelines
Good Clinical Practice is a set of guidelines for biomedical studies which encompasses the design, conduct, termination, audit, analysis, reporting and documentation of the studies involving human participants. Stakeholders are encouraged to submit their comments and suggestions on the draft guidelines. Comments can be submitted electronically within by October 12, 2024 to dci@nic.in.
Prohibition of Manufacture, Sale and Distribution Of S(+)Etodolac + Paracetamol
The Drugs Technical Advisory Board (DTAB) was tasked with examining the necessity of prohibition of the FDC. After careful deliberation and considering the scientific evidence, the DTAB concluded that the FDC lacked therapeutic justification and posed potential risks to human health. This finding was instrumental in the government’s decision to impose a complete ban on the drug.
BIS Invests in R&D to Drive Standardisation
The Bureau of Indian Standards (BIS) has announced the sanction of 82 research and development (R&D) projects to bolster its standardisation efforts. These projects, awarded to faculty members from institutions like IITs and NITs, will focus on cutting-edge domains such as artificial intelligence, blockchain technology, medical devices, renewable energy, and sustainability.
Ayurveda Research Meets Industry at PRAGATI-2024
The interactive meeting aims to explore research opportunities and collaborations between CCRAS and the Ayurveda drug industry. It also aims to maximize the potential of Ayurveda stakeholders by connecting researchers with industry partners. Ultimately, it will also benefit Ayurvedic practitioners and patients.
Institute of Teaching and Research in Ayurveda, Doctor of Philosophy Regulations, 2024
Under these regulations, all matters concerning the Ph.D. program at the Institute will be overseen by Research Committees, with general supervision from the Governing body. Applicants for the doctoral program will be classified into various categories based on their funding source or employment status. Admissions to the Ph.D. program will be conducted annually, with entrance tests typically held in October-November. The Institute will publish an academic calendar specifying all important dates related to the admission process, including advertisement, application submission, and entrance test results.
WHO to Include Ayurveda, Siddha, Unani Morbidity Codes
The ICD series by WHO serves as a global standard for classifying diseases, providing a common language for health information. While the existing data primarily reflects modern biomedical practices, the upcoming ICD 11 TM Module 2 aims to incorporate data and terminology from Ayurveda, Siddha, and Unani (ASU) systems, bringing global uniformity to the classification of traditional medicine.
